results of this study also confirmed a lower incidence of clinically significant patent ductus arteriosus in infants who received prophylactic indomethacin in contrast to those who received placebo ( 11 % v 42 % , p less than .001 ) .
C0013274
patent ductus
C0021246
indomethacin